OCUPHIRE PHARMA INC (OCUP) Stock Income Statement
NASDAQ:OCUP - Nasdaq - US67577R1023 - Common Stock - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 16.45M | 19.05M | 39.85M | 590.00K | 0.00 | |||
| Operating Expenses | 30.13M | 27.61M | 21.62M | 23.29M | 9.46M | |||
| Research and Development | 18.17M | 17.65M | 14.36M | 15.17M | 6.65M | |||
| Selling, General, and Administrative Expenses | 11.96M | 9.96M | 7.27M | 8.12M | 2.82M | |||
| Operating Income | -13.68M | -8.56M | 18.23M | -22.70M | -9.46M | |||
| Interest Income/Expense | N/A | -1.25M | -10.00K | -33.83M | -8.33M | |||
| Other Income/Expense | 2.24M | 1.84M | -10.00K | -160.00K | 10.00K | |||
| Non Recurring Items | N/A | -2.00M | N/A | 0.00 | -6.83M | |||
| Income Before Taxes | -14.09M | -9.97M | 18.20M | -56.69M | -24.62M | |||
| Income Tax | N/A | 12.00K | 320.00K | 0.00 | 0.00 | |||
| Net Income | -14.11M | -9.99M | 17.89M | -56.69M | -24.62M | |||
| EBITDA | N/A | -8.56M | N/A | N/A | -9.45M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.55 | -0.46 | 0.87 | -3.82 | -5.28 | |||
| Non GAAP EPS | -0.55 | -0.48 | 0.76 | -1.59 | -6.28 | |||
| Statistics | ||||||||
| Profit Margin | -85.73% | -52.42% | 44.89% | -9608.47% | N/A | |||
| Operating Profit Margin | -83.11% | -44.95% | 45.75% | -3847.46% | N/A | |||
All data in USD